Breast Cancer, Cancer Research, JAMA, Weight Research / 13.05.2026

MedicalResearch.com Interview with: [caption id="attachment_73639" align="alignleft" width="125"]Bernard F. Fuemmeler, PhD, MPHProfessor and Gordon D. Ginder, MD Chair in Cancer Research Associate Director of Population Science, Massey Comprehensive Cancer Center Director of Research, Family Medicine and Population Health Dr. Fuemmeler[/caption] Bernard F. Fuemmeler, PhD, MPH Professor and Gordon D. Ginder, MD Chair in Cancer Research Associate Director of Population Science, Massey Comprehensive Cancer Center Director of Research, Family Medicine and Population Health [caption id="attachment_73640" align="alignleft" width="125"]Kristina L. Tatum, PsyD, MSInstructor Department of Social and Behavioral Sciences School of Public Health Dr. Tatum[/caption] Kristina L. Tatum, PsyD, MS Instructor Department of Social and Behavioral Sciences School of Public Health A large population-based analysis of more than 841,000 breast cancer patients across the United States examines whether GLP-1 receptor agonist use is associated with improved survival and lower recurrence risk — with findings that researchers describe as very promising.
MedicalResearch.com: What is the background for this study? What are the main findings? Response: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used since 2005 and as the GLP1RAs treatments and delivery methods have improved, their use has markedly increased. Now it is estimated that nearly 1 in 8 US adults report ever using a GLP-1RA, which includes many people who are using them to treat obesity, diabetes, heart disease, and sleep apnea. There has been some preclinical data from mouse models to suggest that maybe GLP1RAs have an anticancer effect reducing the effects of obesity on tumor growth or progression. We were interested to understand to what extent GLP1RA use among cancer patients might be associated with cancer outcomes, like length of survival after cancer treatment or the chance of recurrence. In our large population-based study using an aggregate of de-identified electronic health record data from more than 841,000 patients with breast cancer across the US, we found that GLP-1 RAs use was associated with significantly improved survival and lower recurrence risk among patients with obesity or type 2 diabetes. Among patients with obesity, GLP-1 RAs use was associated with approximately 65% lower risk of death and a 56% lower risk of recurrence over 10 years compared with nonuse. We also observed substantially improved outcomes among patients with type 2 diabetes compared with insulin or metformin.
Weight Research / 11.05.2026

weight-loss-with-new-oral-medications.png

Key Takeaways

     
  • GLP-1 medications have revolutionized weight loss treatment, offering both injectable and oral options.
  • Recent FDA approvals have expanded access to these medications, with new oral formulations now available.
  • While effective, GLP-1 medications can have side effects, emphasizing the need for medical supervision.
  • Incorporating dietary fiber can help mitigate some gastrointestinal side effects associated with GLP-1 medications.
 

Table of Contents

  1. Introduction
  2. Understanding GLP-1 Medications
  3. Recent FDA Approvals
  4. Potential Side Effects
  5. Dietary Considerations
  6. Importance of Medical Supervision
  7. Conclusion
 

Introduction

In recent years, the field of weight management has experienced significant changes, thanks to a class of drugs called GLP-1 receptor agonists. These medications, which started as treatments for type 2 diabetes, have demonstrated remarkable success in supporting weight loss. Their widespread acceptance and endorsements by healthcare providers stem from their ability to help users not only lose weight but also maintain healthier lifestyles over the long term. Individuals seeking up-to-date and reputable information on options like Semaglutide for Weight Loss can explore how these solutions have changed the landscape of obesity treatment. In recent years, the field of weight management has experienced significant changes, thanks to a class of drugs called GLP-1 receptor agonists. These medications, which started as treatments for type 2 diabetes, have demonstrated remarkable success in supporting weight loss. Their widespread acceptance and endorsements by healthcare providers stem from their ability to help users not only lose weight but also maintain healthier lifestyles over the long term. GLP-1 medications are reshaping how both doctors and patients approach chronic weight issues. Unlike older interventions, these medications address appetite regulation at a hormonal level. With the introduction of oral alternatives, more people can now benefit from these scientifically backed therapies.
Sleep Disorders, Weight Research / 30.04.2026

[caption id="attachment_73537" align="aligncenter" width="500"]fix-sleep-fix-diet.jpg Pexels[/caption] You're tracking your food. You're showing up at the gym. The scale isn't moving. The clothes still fit the same. And somewhere underneath the frustration is a quieter symptom you've been ignoring because it doesn't seem related: you haven't actually slept well in months. Here's the part most weight loss conversations skip. The relationship between sleep and weight isn't a wellness slogan. It's a measurable physiological mechanism, and for a meaningful number of people, fixing the sleep is the missing variable that finally lets the rest of the work pay off.

The Mechanisms Are More Specific Than People Realize

Three things happen when sleep is chronically short or fragmented, and they stack.

Hunger Hormones Shift

Two hormones regulate appetite: ghrelin (which says "eat") and leptin (which says "stop"). After even a few nights of restricted sleep, ghrelin rises and leptin drops. The result, measured repeatedly in controlled studies, is that sleep-deprived people eat several hundred extra calories the next day without registering any change in willpower or intention.

Cravings Get More Specific

Sleep loss specifically increases cravings for high-calorie, high-carbohydrate foods. Brain imaging shows reduced activity in the prefrontal cortex (decision-making) and increased activity in reward centers when sleep is short. The food choices feel like preference. They're partly chemistry.

Insulin Sensitivity Drops

Even short stretches of poor sleep reduce insulin sensitivity, meaning the body processes carbohydrates less efficiently and stores more of them as fat. This is one of the more striking findings in recent metabolic research — and it shows up after as little as a week of restricted sleep in otherwise healthy adults.
Weight Research / 15.04.2026

[caption id="attachment_73307" align="aligncenter" width="500"]weight-loss-myths.png Photo courtesy of Pexels[/caption] If you’ve ever looked up weight loss tips, you’ve probably seen a mix of advice that sounds convincing but doesn’t always hold up in real life. Just like you might check a healthy Costco snacks guide to make smarter choices, it’s just as important to filter out myths that can slow down your progress. Let’s break down some of the most common ones and what actually works instead. Let's break down some of the most common weight loss myths — and what actually works instead.

1. "Healthy" Packaged Foods Always Help With Weight Loss

Just because something is labeled "healthy" doesn't mean it's good for weight loss. Many packaged foods are still high in calories, sugar, or portion sizes that are easy to overeat. Even healthier options can slow progress if you're not mindful. Do your research on what healthy snacks are available — you can start by checking a healthy Costco snacks guide to understand better options and make more informed food choices. Check portion sizes rather than just labels, keep snacks simple (nuts, fruit, yogurt), and avoid mindless eating even with "healthy" foods.
Weight Research / 30.12.2025

nonrestrictive-diet.jpg In recent years, the focus on personal health and fitness has significantly increased as individuals seek to improve their quality of life. Technological advances and a deeper understanding of nutrition and exercise have introduced new methods to aid in achieving health goals. One such method that stands out is efficient weight loss treatment​. Understanding and exploring the best options is crucial for anyone embarking on a journey toward better health.

Understanding Weight Loss Treatment

Weight loss treatment isn't merely about dieting and exercising; it encompasses a comprehensive approach tailored to suit individual needs. The goal is a sustainable lifestyle change that not only helps lose weight but also enhances overall well-being. Treatments varying from medication, behavioural therapy, to surgical intervention are available and should be chosen based on careful consideration and professional guidance.
Author Interviews, Weight Research / 08.12.2025

Editors' note: Retatrutide and Orforglipron are investigational drugs not yet approved by the FDA or available in the US.  This post is for informational purposes only and not medical advice.  Please discuss your weight loss goals with your health care provider. [caption id="attachment_68088" align="aligncenter" width="500"]\weight-loss-semaglutide Pexels[/caption]

Why has the global research community shifted so rapidly from single-agonist therapies like Semaglutide toward multi-agonist therapies?

Semaglutide (a GLP-1 receptor agonist) represented a major pharmacological breakthrough, delivering approximately 11–12% mean weight reduction in obesity trials, far surpassing older treatments. However, emerging clinical data suggest that the therapeutic ceiling for single-pathway modulation has largely been reached. Obesity is not driven by a single metabolic defect. It is a multi-system hormonal disease, involving impaired satiety signaling, dysregulated adipocyte metabolism, altered hepatic lipid handling, and reduced energy expenditure. As a result, the industry has shifted toward multi-agonist therapies capable of simultaneously activating several metabolic pathways. This shift mirrors oncology and cardiology, where combination therapies routinely outperform single-target interventions. In obesity pharmacology, dual and now triple agonists are demonstrating precisely that pattern.
Author Interviews, Sleep Disorders, Weight Research / 05.11.2025

[caption id="attachment_71296" align="aligncenter" width="500"]sleep-apnea-and-weight Photo by Kampus Production[/caption]

Introduction

Does your bed partner report loud snoring followed by periods of silence? Sleep apnoea occurs when throat muscles relax excessively during sleep, blocking airflow for 10 seconds or longer. Three modifiable factors—body weight, alcohol consumption, and sleeping position—directly influence how often these breathing interruptions occur and their severity. If you’re experiencing persistent snoring or disrupted sleep, consulting a sleep specialist Singapore can help determine which of these factors contribute most to your condition. Weight adds pressure to airways through neck fat deposits and abdominal pressure on the diaphragm. Alcohol relaxes throat muscles beyond normal sleep relaxation, increasing airway collapse. Back sleeping allows gravity to pull the tongue and soft tissues backward, narrowing the airway further. Addressing these factors may reduce apnoea episodes, sometimes reducing the need for continuous positive airway pressure (CPAP) therapy.
Author Interviews, Cancer Research, JAMA, Weight Research / 02.11.2025

MedicalResearch.com Interview with: [caption id="attachment_71229" align="alignleft" width="125"]Dr. Bian Jiang Dr. Bian Jiang[/caption] Jiang Bian, PhD Associate Dean of Data Science Walther and Regenstrief Professor of Cancer Informatics Professor of Biostatistics & Health Data Science Adjunct Professor, Biomedical Engineering and Informatics Chief Data Scientist, Regenstrief Institute Chief Data ScientistCustomize & Schedule Social Media Posts Indiana University Health [caption id="attachment_71230" align="alignleft" width="125"]Serena Jingchuan Guo Dr. Serena Guo[/caption] Serena Jingchuan Guo, MD PhD Assistant Professor Department of Pharmaceutical Outcomes and Policy University of Florida College of Pharmacy [caption id="attachment_71231" align="alignleft" width="125"]Hao Dai, PhD Dr. Hao Dai[/caption] Hao Dai, PhD Postdoctoral Fellow Department of Biostatistics & Health Data Science Indiana University School of Medicine       MedicalResearch.com: What is the background for this study? What are the main findings? Response: Obesity and type 2 diabetes are both known to increase the risk of several cancers. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become very popular for both glycemic control and weight loss, but their long-term effects on cancer risk are still unclear. Using a large real-world dataset, we emulated a target trial comparing more than 43,000 GLP-1RA users to matched non-users. We found that GLP-1RA use was associated with a significantly lower overall cancer risk.
Author Interviews, Diabetes, Kidney Disease, NYU/NYMC, Weight Research / 20.10.2025

MedicalResearch.com Interview with: [caption id="attachment_71025" align="alignleft" width="225"]Michael A. Weintraub, MDClinical Assistant Professor Department of Medicine NYU Grossman School of Medicine Dr. Weintraub[/caption] Michael A. Weintraub, MD Clinical Assistant Professor Department of Medicine NYU Grossman School of Medicine MedicalResearch.com: What is the background for this study? Response: The study addresses a critical knowledge gap in diabetes management for dialysis patients. Of the 808,000 people on dialysis in the United States, approximately 60% have diabetes and would be eligible for GLP-1 receptor agonists (GLP-1 RAs). However, these medications have not been well-studied in this population because dialysis dependence is frequently an exclusion criterion in clinical trials.
Author Interviews, Weight Research / 08.10.2025

GLP-1 Medications For Weight Loss: Benefits and Potential Side Effects

[caption id="attachment_70925" align="aligncenter" width="500"]weight-loss-drugs-semaglutide Photo by Suzy Hazelwood[/caption] By Palvinder Deol, Superintendent Pharmacist, Happy Pharmacy Obesity is a complex, multifactorial disease that continues to pose one of the greatest public health challenges of our time. According to the World Health Organization, global obesity rates have nearly tripled since 1975, with more than one billion adults now classified as overweight or obese. Despite growing awareness of the health risks associated with excess weight — including cardiovascular disease, type 2 diabetes, and certain cancers — achieving and sustaining weight loss remains difficult for many individuals. Over the past few years, advances in pharmacological science have transformed the landscape of obesity management. Treatments targeting hormonal pathways, particularly GLP-1 receptor agonists, have shown remarkable efficacy in supporting meaningful, long-term weight reduction when combined with healthy lifestyle changes.
Author Interviews, COVID -19 Coronavirus, Pediatrics, Weight Research / 09.09.2025

MedicalResearch.com Interview with: [caption id="attachment_70576" align="alignleft" width="200"]Thao-Ly Phan, MD, MPH Medical Director, Nemours Children's Health Professor of Pediatrics Thomas Jefferson University Dr. Thao Ly Phan[/caption] Thao-Ly Phan, MD, MPH Medical Director, Nemours Children's Health Professor of Pediatrics Thomas Jefferson University MedicalResearch.com: What is the background for this study? Response: The impacts of the COVID-19 pandemic have been extensively studied in adults, but there has been limited exploration of its effects on children and adolescents. While several studies have described weight gain trends in children during the pandemic, less is known about how having a diagnosis of COVID-19 contributed to these trends. Our study drew on the NIH’s National Clinical Cohort Collaborative database, a real-world database of electronic health data from over 90 institutions across the country.  We used this dataset’s unique features to compare a diverse group of more than 11,000 children diagnosed with COVID-19 to a matched cohort of children without a diagnosis of COVID-19.
Weight Research / 06.09.2025

[caption id="attachment_70560" align="aligncenter" width="500"]obesity-meds-pills Photo by Julie Viken[/caption] For decades, weight management has been a frustrating cycle for many people—dieting, exercising, seeing progress, only to experience setbacks. While lifestyle changes remain essential, science has advanced rapidly in offering medical tools to support those living with obesity and related conditions. One of the most significant breakthroughs in recent years has been the arrival of medications that target specific pathways in the body to regulate appetite, improve blood sugar, and support sustainable weight loss. The shift from injectables to pills may seem like a simple matter of convenience, but it represents a significant turning point in obesity treatment. Pills could broaden access, reduce stigma, and remove barriers that keep many people from starting or staying on therapy. For clinicians and patients alike, this is an exciting and complex moment, one that raises questions about how treatment will evolve and who will benefit most.
Weight Research / 26.08.2025

how-medical-weight-loss-programs-help-lose-weight.jpg

Why “Safe” Weight Loss Matters

In a world saturated with fad diets, social media trends, and quick-fix weight loss pills, finding a truly safe way to shed pounds can feel like searching for a needle in a haystack. Many people start with enthusiasm only to experience health risks, nutritional deficiencies, or rapid weight regain. The truth is, losing weight safely requires more than willpower; it requires medical insight, evidence-based strategies, and ongoing support. Medical weight loss programs provide exactly that. They are designed and supervised by healthcare professionals to help individuals lose weight in a way that protects their health, addresses underlying conditions, and promotes sustainable results. Unlike commercial diet programs, medical weight loss plans are rooted in science, tailored to the individual, and focused on long-term wellness.
Weight Research / 07.08.2025

MedicalResearch.com Interview with: [caption id="attachment_70205" align="alignleft" width="125"]Shannon D. DonofryBehavioral Scientist B.A.Sc. in psychology/neuroscience University of Pittsburgh-Pittsburgh Campus; Ph.D, University of Pittsburgh-Pittsburgh Campus Dr. Donofry[/caption] Shannon D. Donofry Ph.D. Behavioral Scientist B.A.Sc. in psychology/neuroscience University of Pittsburgh-Pittsburgh Campus; Ph.D, University of Pittsburgh-Pittsburgh Campus   [caption id="attachment_70207" align="alignleft" width="125"]Katherine M. Rancaño, Ph.DAssociate Policy Researcher RAND Dr. Rancaño[/caption] Katherine M. Rancaño, Ph.D Associate Policy Researcher RAND   MedicalResearch.com: What is the background for this study? Response: GLP-1 medications were first used to help people with diabetes manage their blood sugar. Lately, they’ve become popular for helping people lose weight, too. Because of this, a lot more people have started using them. In our study, we asked over 8,000 adults from across the country about their use of GLP-1 medications and any side effects they had.
Supplements, Weight Research / 10.07.2025

Please note: Supplements are not FDA tested or approved. Some supplements can interfere with medications and/or cause side effects. Do not delay seeking medical attention for medical concerns by taking supplements without medical advice. Please discuss any and all supplements you take with your health care provider. [caption id="attachment_69457" align="aligncenter" width="500"]weight-management-fat-loss-supplement Photo by Gustavo Fring[/caption] In the contemporary pursuit of health and fitness, individuals are continuously on the lookout for effective strategies to manage weight and reduce body fat. The weight management industry is inundated with various supplements and products, each claiming to offer a solution to achieving weight loss goals. Amidst this backdrop, oxyshred has emerged as a product that has garnered attention for its potential to assist with weight management and fat loss.

Understanding the Role of Supplements in Weight Management

Weight management is a complex process that involves a balanced diet, regular physical activity, and a healthy lifestyle. Supplements are often introduced to support these efforts, providing the body with additional nutrients and compounds that may aid in enhancing metabolism, curbing appetite, or increasing energy expenditure. While supplements can play a supportive role, they should not be regarded as a standalone solution for weight loss.
Weight Research / 30.06.2025

Potential Risks of Using Ozempic and Rybelsus Ozempic and Rybelsus are medications that have become increasingly popular for managing type 2 diabetes and, more recently, for off-label use in weight loss. Both drugs contain semaglutide, a compound that mimics a hormone that is involved in the regulation of blood sugar and control of appetite. These drugs do work for many patients, but they are not without risk. With their use increasing, concern has grown over potential side effects. As more patients turn to these medications, it's essential to weigh the benefits against the risks. Understanding how each drug affects the body can help make safer choices. That’s why an Ozempic vs Rybelsus safety comparison is key for anyone considering these treatments.

1.   Gastrointestinal Issues

One of the most common side effects patients report experiencing with Ozempic and Rybelsus is gastrointestinal discomfort. Patients often report nausea, vomiting, diarrhea, and abdominal pain, especially when treatment is initiated or the dose is adjusted. These symptoms can be mild and last a few weeks. Such discomfort is sometimes severe enough to result in dehydration or discontinuation of therapy. This can exacerbate symptoms in individuals who already have other pre-existing digestive problems.
Nutrition, Protein, Weight Research / 11.06.2025

[caption id="attachment_68981" align="aligncenter" width="500"]protein-shake-glp-shake Photo by Photo By: Kaboompics.com[/caption]

Key Takeaways

  • Functional ingredients like adaptogens, probiotics, and plant-based proteins are moving shakes beyond meal replacement status and making them vital tools in modern wellness routines.
  • Solid clinical evidence underpins the advantages of many trending components in innovative shakes, highlighting their potential for holistic health support.
  • Careful analysis of nutrition labels and ingredient sourcing is essential for consumers aiming to make healthier shake choices.
  • Personalization options and on-the-go convenience have catapulted innovative shakes into everyday life, catering to diverse dietary needs.
  • Current market movements reflect an exciting era of innovation, emphasizing taste and tangible health benefits in shake offerings.
 

What Are Smart Shakes?

Today's innovative shakes are designed with intention and scientific rigor, offering a sharp contrast to the single-nutrient protein shakes of years past. Instead of focusing on muscle recovery, these shakes incorporate a broader spectrum of health-promoting nutrients, from vitamins and minerals to plant-based adaptogens and live cultures. A GLP-1 protein shake perfectly represents this trend, crafted to support wellness through thoughtfully selected ingredients that go well beyond protein content. Such shakes often claim to help with satiety, energy, and metabolic health, catering to those wanting more than simple calorie replacement. This evolution in the shake market is about more than just ingredients—it's a response to busy, health-conscious lifestyles. People juggling careers, family, and fitness often need a fast, efficient breakfast, lunch, or post-gym recovery solution. Innovative shakes meet this demand, acting as versatile, portable meal options. Importantly, they appeal to athletes and anyone who values proactive health measures, including students, professionals, and parents. Instead of settling for generic "one-size-fits-all" blends, individuals seek shakes with functional ingredients promising tailored benefits, from immune support to cognitive clarity to sustainable energy throughout the day.
Addiction, Mental Health Research, Weight Research / 30.05.2025

[caption id="attachment_68870" align="aligncenter" width="500"]time-to-treat-eating-disorder Photo by SHVETS production[/caption] Eating disorders affect millions of women in the U.S., yet many go untreated for years. Often masked by diet culture, anxiety, or perfectionism, these conditions can be difficult to recognize—even by those experiencing them. But when an eating disorder begins to interfere with daily life, relationships, and physical health, it may be time to seek help. Treatment isn’t just for extreme cases. Recovery becomes possible the moment the behavior is acknowledged for what it is: a serious medical and psychological condition that deserves attention. Recognizing When It’s More Than a Phase An eating disorder doesn’t always start with an obvious warning sign. It may begin with subtle restrictions, excessive exercise, or occasional bingeing, and gradually take over a woman’s sense of control, worth, and health. What’s often mistaken as “discipline” or “healthy living” can quietly escalate into a full-blown disorder that dominates thoughts, daily habits, and physical well-being. Women living with these patterns may not appear underweight. Many continue to work, socialize, or appear physically well while privately struggling with behaviors that damage both body and mind. Missed menstrual cycles, hair thinning, mood swings, and digestive issues are just a few of the common warning signs that the body is no longer coping well. These symptoms should not be brushed off as stress or fatigue. When food becomes a constant mental focus, or when guilt, shame, and secrecy follow meals, it’s a strong indicator that help may be necessary.
Nutrition, Weight Research / 24.05.2025

[caption id="attachment_68936" align="aligncenter" width="500"]healthy food satiety Photo by Pixabay[/caption] In today's world of fad diets and miracle weight loss solutions, many are turning to medications like Ozempic for weight loss. However, nature offers several powerful approaches that can help reduce food intake naturally—without prescriptions or side effects. Let's explore how you can harness a natural alternative to Ozempic to feel satisfied with less food while still nourishing your body properly. 80Bites: The Original "Natural Ozempic" Long before weight-loss medications hit the market, the 80Bites approach pioneered the concept of portion training as the key to sustainable weight management. This methodology focuses on a simple principle: it's not just what you eat, but how much and how often that matters. The 80Bites plan gets its name from research suggesting that the human stomach is designed to comfortably process a maximum of 80 normal-sized bites of food per day. By tracking and gradually reducing your daily bite count to around this target, you naturally train your stomach to feel satisfied with less food volume and you rebalance your hormones so that leptin and ghrelin work together. Today, because of decades of dieting, obese people are abnormally hungry because their hormones malfunction. Calorie counting can lead to binging as a result of eating foods that may not satisfy but are on the diet because they are low in calories and are unlimited in terms of quantity. The 80Bites approach focuses purely on quantity. This allows you to eat the foods you enjoy. Does anyone know what kale tastes like in someone else’s mouth?
Author Interviews, Gastrointestinal Disease, Hepatitis - Liver Disease, Weight Research / 07.05.2025

[caption id="attachment_68344" align="alignleft" width="200"]MedicalResearch.com Interview with:Dr. Katilyn Gernhard Dr. Gernhard[/caption] MedicalResearch.com Interview with: Dr. Katilyn Gernhard DO Internal Medicine Resident Allegheny Health Network Pittsburgh MedicalResearch.com: What is the background for this study? Response: The background for this study is the steadily rising prevalence of obesity in the United States, which has been accompanied by an increase in related comorbid conditions, including Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). Bariatric surgery and GLP-1 receptor agonists are two commonly used treatment options to address obesity and its associated complications. While both have demonstrated benefits in weight loss and metabolic improvement, there has been limited direct comparison of their effectiveness specifically in patients with MASLD. Our study aimed to address this gap by comparing clinical outcomes in patients with MASLD treated with GLP-1 receptor agonists versus those treated with bariatric surgery.
Alzheimer's - Dementia, Author Interviews, Diabetes, JAMA, Weight Research / 09.04.2025

MedicalResearch.com Interview with: [caption id="attachment_67848" align="alignleft" width="150"]Dr. Catriona Reddin MDFourth year Specialist Registrar in Geriatric Medicine  and an Irish Clinical Academic Training (ICAT) fellow University Hospital Galway, Galway, Ireland Dr. Reddin[/caption] Dr. Catriona Reddin MD Fourth year Specialist Registrar in Geriatric Medicine  and an Irish Clinical Academic Training (ICAT) fellow University Hospital Galway, Galway, Ireland   MedicalResearch.com: What is the background for this study? Response: Dementia is a leading cause of disability globally, which is projected to affect approximately 75 million people by 2030. Diabetes mellitus is a risk factor for dementia, it was unclear if glucose lower therapies reduce the risk of dementia. The research, a systematic review and meta-analysis of 26 clinical trials involving over 160,000 participants, found that while most glucose-lowering therapies were not significantly associated with a reduction in dementia risk, one class of drugs—GLP-1Ras—was linked to a significant reduction.
Weight Research / 09.04.2025

For decades, achieving the dream body has been a pursuit often tangled in unrealistic expectations and unsustainable methods. We're told to count calories meticulously, follow strict workout regimens, and sacrifice joy at the altar of discipline. And while nutrition and physical activity remain foundational, the modern wellness world has evolved enter weight loss injections. This innovative approach is not a miracle cure, nor is it a shortcut for laziness. Rather, it's an evidence-based tool helping thousands break through biological barriers, hormonal blocks, and metabolic plateaus that once seemed insurmountable. The dream body? It's not about six-pack abs or size-zero jeans. It’s about confidence, vitality, and the freedom to live without constantly battling your body. [caption id="attachment_67840" align="aligncenter" width="500"]Dream Body with the Help of Weight Loss Injections Image Source[/caption] In today’s fast-paced society, where time is scarce and stress is abundant, traditional fitness models are no longer sufficient for everyone. Despite the most valiant efforts, some bodies resist change. Genetics plays a role. So do hormones, age, medical conditions, and mental health. That’s where medically supervised interventions like weight loss injections provide a spark of hope. They don't erase the importance of healthy living they enhance it. They optimize your body’s potential to burn fat, curb hunger, and recalibrate metabolism. More than anything, they level the playing field.
Author Interviews, Weight Research / 20.03.2025

[caption id="attachment_67204" align="alignleft" width="200"] Prof. El GHOCH[/caption] MedicalResearch.com Interview with: Prof. Marwan EL GHOCH Professore Associato in Scienza dell'Alimentazione e Tecniche Dietetiche Applicate MEDS-08/C Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze Università di Modena e Reggio Emilia Modena, 41125, Italy MedicalResearch.com: What is the background for this study? Response: Body mass index (BMI) is an easy-to-use tool to determine an individual’s by classifying him/her as having normal weight, overweight, or obesity, and this is based on universal cut-off points suggested by the World Health Organization (WHO) for all age groups. Not taking into account the potential changes that may occur to body composition compartments during the individual’s lifespan. In fact, little is still known about this topic in people with overweight and obesity. For this reason our study aimed to compare the body composition compartments between three different age groups (young, middle-age, and older adults), adopting a design that matched these 3 age groups by BMI.
Weight Research / 29.01.2025

weight-loss-poster.jpg Desperate to shape up, many people swallow the latest pill or potion, jump on the latest diet bandwagon, or try some quick-fix gizmo that guarantees rapid weight loss. Beneath their seductive appeal, these fixes usually lack staying power, leaving us vulnerable to unintended physical and mental consequences that can be frustrating. Medications like Mounjaro, while effective for specific medical conditions, may not be the best solution for long-term weight management. Imagine having the energy and confidence to take on each new day. By making smart food choices, staying active, and swapping unhealthy habits for healthier ones, you can achieve just that.
Weight Research / 26.12.2024

Weight loss medications have become such a game-changer. For years, weight loss was all about diet and exercise, which can be a real uphill battle for most folks. But now, with medications like Mounjaro showing such promising results real progress has been made in the fight against obesity. Even with a game-changing drug like Mounjaro, there's still a learning curve. And one of the most common questions patients ask is: "Where's the best place to inject this medication?" [caption id="attachment_65674" align="aligncenter" width="500"]obese-abdomen-obesity-drugs Photo by Towfiqu barbhuiya[/caption]

What is Mounjaro?

Mounjaro, also known by its generic name Tirzepatide, is a relatively new medication making waves in the weight loss world. It mimics the effects of two naturally occurring hormones in the body: GLP-1 and GIP. These hormones regulate blood sugar levels, appetite, and metabolism. Semaglutide class of medications on the other hand like Ozempic for weight loss, contain a GLP-1 receptor agonist. Mounjaro is actually FDA-approved for treating type 2 diabetes. But it also has an impressive side effect: weight loss. And not just a little bit of weight loss, either. We're talking double-digit percentages here. So, while Mounjaro isn't officially approved for weight loss, many doctors are prescribing it off-label to help patients achieve their weight loss goals.